Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate

Pernille M Christensen1, Catherine H Liu2, Steven L Swendeman2

  • 1Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark; Department of Biomedical Sciences University of Copenhagen, Copenhagen, Denmark;

Insights

Apolipoprotein M deficiency reduces plasma sphingosine-1-phosphate, increasing vascular leakage. Restoring ApoM/S1P or activating S1P1 receptors reverses this, highlighting S1P1

Area of Science:

  • Vascular biology
  • Lipid metabolism
  • Inflammation research

Background:

  • Apolipoprotein M (ApoM) is a key transporter of sphingosine-1-phosphate (S1P) in plasma.
  • Reduced plasma S1P levels are observed in ApoM-deficient mice (Apom(-/-)).
  • S1P signaling through the S1P1 receptor is crucial for maintaining endothelial barrier integrity and suppressing vascular leak.

Purpose of the Study:

  • To investigate the link between ApoM deficiency, vascular leakage, and S1P1 receptor function.
  • To determine if impaired endothelial barrier function in ApoM deficiency is S1P1-dependent.
  • To assess the impact of ApoM deficiency on vascular permeability during inflammation.

Main Methods:

  • Assessment of lung vascular permeability using dextran accumulation in ApoM-deficient and wild-type mice.
  • Pharmacological intervention with an S1P1 receptor agonist (SEW2871).
  • ApoM/S1P reconstitution experiments and adenoviral gene delivery in Apom(-/-) mice.
  • Carrageenan-induced inflammation model to evaluate vascular leakage.

Main Results:

  • Apom(-/-) mice exhibited approximately 40% increased vascular permeability in the lungs compared to wild-type mice.
  • Treatment with SEW2871 or reconstitution of plasma ApoM/S1P rapidly normalized vascular leakage in Apom(-/-) mice.
  • ApoM deficiency exacerbated carrageenan-induced vascular leakage, which was attenuated by adenoviral ApoM overexpression.
  • Vascular leakage of albumin-sized particles in ApoM deficiency is dependent on S1P and S1P1 signaling.

Conclusions:

  • Impaired endothelial barrier function in ApoM deficiency is primarily due to reduced S1P levels and subsequent decreased S1P1 receptor stimulation.
  • The S1P-S1P1 pathway is critical for maintaining vascular integrity.
  • ApoM deficiency exacerbates inflammatory responses by compromising the endothelial barrier function in an S1P1-dependent manner.